| Autor: |
Jing-Cai Liu, Yong-Wei Zhu, Ri-Hong Chen |
| Jazyk: |
angličtina |
| Rok vydání: |
2013 |
| Předmět: |
|
| Zdroj: |
Guoji Yanke Zazhi, Vol 13, Iss 7, Pp 1490-1491 (2013) |
| Druh dokumentu: |
article |
| ISSN: |
1672-5123 |
| DOI: |
10.3980/j.issn.1672-5123.2013.07.60 |
| Popis: |
AIM: To observe the clinical effect of Hexuemingmu tablets for the treatment of subconjunctival hemorrhage, and to seek a treatment which can shorten the course of disease and improve the efficacy. METHODS: Eighty-two(82 eyes)patients randomly received either Hexuemingmu tablets treatment(n=50 cases)or Vitamin C treatment(n=32 cases). Patients were treated with Hexuemingmu tablets(5 tablets)or Vitamin C(0.2g)by oral drugs(3 times a day)respectively. They were clinical observed.RESULTS: After 1 month,among 50 patients treated with Hexuemingmu tablets, 40 patients were cured, 7 patients were improved and 3 patients were invalid. The total effective rate was 94%(47/50). While in Vitamin C group, 32 patients were treated, 16 patients were cured, 9 patients were improved, and 7 patients were invalid. The total effective rate was 78%(25/32). There was a significant statistical difference between the two groups(P=0.015CONCLUSION: It is effective, easy and safe to use Hexuemingmu tablets for the treatment of subconjunctival hemorrhage. It is worthy to be popularized in clinical treatment. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
